Basic Ordering Agreement N0018925GZ097

Award Date 7/15/25
Last Date to Order 7/14/35
Funding Federal Agency
Bureau of Medicine and Surgery
Contracting Federal Agency
Naval Supply Systems Command
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the University of Texas Medical Branch at Galveston (UTMB), a state-controlled institution of higher learning. The contract, valued at a ceiling of $100,000, focuses on biomedical research and exploration, with a specific task order extending the period of performance to September 30, 2010. UTMB, as a prime contractor, has demonstrated significant expertise in...
The University of Texas Medical Branch at Galveston (UTMB) holds a single award indefinite delivery contract (IDC) with the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The $67.4 million IDC, awarded on September 15, 2003, provides NIAID with a flexible contracting mechanism to efficiently order a range of preclinical research and development services from UTMB to support the evaluation of candidate...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to the University of Texas Medical Branch at Galveston (UTMB) to provide preclinical models and services for the development and evaluation of medical countermeasures against infectious diseases. The $146.3M single-award IDC has a 7-year ordering period and covers four task areas: (A) small animal...
The federal contract IDV is an Indefinite Delivery Contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The University of Texas Health Science Center at San Antonio (UTHSCSA) to provide pre-clinical models of infectious diseases for up to $146.3 million over a period of 7 years. The contract supports NIAID's mission to understand, treat, and prevent infectious diseases by developing and refining small animal, non-human primate, and...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The University of North Texas Health Science Center at Fort Worth (UNTHSC) as a single award with a $146,300,000 ceiling value and a period of performance through July 2031. The contract is for the provision of pre-clinical models of infectious diseases, including the development and refinement of small animal, non-human primate, and animal...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to Utah State University (USU) on July 15, 2024. The $146.3 million, single-award IDC has a period of performance through July 14, 2031 and is focused on providing pre-clinical models of infectious diseases. The contract aims to procure a range of services from USU, including the development and refinement of small animal, non-human primate, and...
The National Institute of Allergy and Infectious Diseases awarded multiple Indefinite Delivery/Indefinite Quantity contracts to provide preclinical development support for candidate products and drug development activities ranging from initial discovery to clinical trials. Services are conducted under seven task areas including in vitro testing, synthesis of therapeutic agents, small animal models for HIV/HBV/HCV and mycobacterium, formulation development, preclinical pharmacology and...
The indefinite delivery contract HHSN272201700031I was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to the Texas A&M University System Health Science Center. This multiple award contract has a ceiling value of $40,000,000 and a period of performance from July 2017 to July 2024. It is part of the NIAID Preclinical Models of Infectious Diseases 2017-2024 master IDIQ contract. The contract...
This indefinite delivery contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to the Texas Biomedical Research Institute (TBRI) as a single award. The contract has a ceiling value of $136,588,701 and a period of performance extending to September 29, 2035. The contract provides for evaluation and testing services (ETS) for vaccines and other biologics targeting infectious diseases. TBRI, a non-profit research organization, will...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a single-award, indefinite delivery contract to the Texas Biomedical Research Institute, doing business as the Southwest Foundation for Biomedical Research. The contract has a potential value of $100 million and a period of performance through September 2027 to provide biological animal model and medical countermeasure development support. Two associated delivery orders have been...

The University of Texas Medical Branch at Galveston (UTMB) has been awarded a single-award Basic Ordering Agreement (BOA) contract by the Bureau of Medicine and Surgery, a Defense agency. The $146.3 million IDC contract is focused on providing comprehensive preclinical testing services for the development of medical countermeasures against emerging infectious diseases, supporting pandemic preparedness and research on high-priority pathogens.

Key contract tasks include providing small animal models, non-human primate models, alternative animal models, and specialized reagent generation services. Individual task orders under this vehicle have ranged from around $370,000 to over $6 million, highlighting UTMB's critical role in the national infectious disease research infrastructure. UTMB also holds significant federal grant awards from the National Institutes of Health, focusing on areas such as viral pathogenesis, neurodegenerative disease research, pregnancy complications, and innovative medical technologies.

Generated 10/13/25, 9:42 AM